Ensartinib Hydrochloride Market to Reach USD 2.9 Billion by 2035 | CAGR 14.7% during the period of 2025–2035
The Ensartinib Hydrochloride Market features a competitive landscape driven by pharmaceutical innovators and biotechnology companies developing targeted therapies for oncology. Key market manufacturers include Xcovery Holdings Inc., Betta Pharmaceuticals Co. Ltd., Pfizer Inc., Novartis AG, Roche Holding AG, AstraZeneca PLC, …